Class II ยท Moderate risk
Terlivaz (terlipressin for injection)
cGMP deviations: Temperature excursion due to shipping delay from manufacturer to distributor. Affected distributor has been notified.
National Drug Code
Is NDC 43825-0200-01 recalled?
Terlivaz · 1 VIAL, SINGLE-DOSE in 1 CARTON (43825-200-01) / 5 mL in 1 VIAL, SINGLE-DOSE
Yes — this exact package was recalled
1 FDA recall names the code 43825-0200-01 directly. A recall still applies to particular lot numbers — compare the lot on your package with the FDA notice below, and talk to your pharmacist before stopping a prescribed medication.
1 of these recalls is still ongoing.
- Active ingredient
- Terlipressin
- Strength
- TERLIPRESSIN .85 mg/5mL
- Form
- Injection, Powder, Lyophilized, for Solution · Intravenous
- Labeler
- Mallinckrodt Hospital Products Inc.
- Type
- Human Prescription Drug
- Product code
- 43825-0200
Recalls naming this package
Where to find this code. The NDC is printed on the pharmacy label and on the manufacturer's carton, usually as three groups of digits after “NDC”. The last group is the package size — two bottles of the same medicine can differ only in that group, and a recall may cover one but not the other.
Other recalled products from this labeler
- 43825-0102 See recall 1
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.